Why We “Scout Ahead”: Navigating the Analytical Landmines of Early-Stage R&D
In the pharmaceutical and specialty chemical industries, the path from a lead compound to a defensible data package is rarely a straight line. While high-volume Contract Research Organizations (CROs) are built for routine testing, they often lack the agility required for the “unknowns” of early-phase R&D or the troubleshooting of complex, legacy methods. The Gap […]